1113 related articles for article (PubMed ID: 24185200)
1. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
2. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
[TBL] [Abstract][Full Text] [Related]
3. The ASAP2 gene is a primary target of 1,25-dihydroxyvitamin D3 in human monocytes and macrophages.
Seuter S; Ryynänen J; Carlberg C
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():12-8. PubMed ID: 23999061
[TBL] [Abstract][Full Text] [Related]
4. What do we learn from the genome-wide perspective on vitamin D3?
Carlberg C
Anticancer Res; 2015 Feb; 35(2):1143-51. PubMed ID: 25667505
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
6. VDR primary targets by genome-wide transcriptional profiling.
Goeman F; De Nicola F; D'Onorio De Meo P; Pallocca M; Elmi B; Castrignanò T; Pesole G; Strano S; Blandino G; Fanciulli M; Muti P
J Steroid Biochem Mol Biol; 2014 Sep; 143():348-56. PubMed ID: 24726990
[TBL] [Abstract][Full Text] [Related]
7. Molecular endocrinology of vitamin D on the epigenome level.
Carlberg C
Mol Cell Endocrinol; 2017 Sep; 453():14-21. PubMed ID: 28315703
[TBL] [Abstract][Full Text] [Related]
8. Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression.
Seuter S; Heikkinen S; Carlberg C
Nucleic Acids Res; 2013 Jan; 41(1):110-24. PubMed ID: 23093607
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D-dependent chromatin association of CTCF in human monocytes.
Neme A; Seuter S; Carlberg C
Biochim Biophys Acta; 2016 Nov; 1859(11):1380-1388. PubMed ID: 27569350
[TBL] [Abstract][Full Text] [Related]
10. The impact of chromatin organization of vitamin D target genes.
Carlberg C; Dunlop TW
Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674
[TBL] [Abstract][Full Text] [Related]
11. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
12. The transcriptional regulator BCL6 participates in the secondary gene regulatory response to vitamin D.
Nurminen V; Neme A; Ryynänen J; Heikkinen S; Seuter S; Carlberg C
Biochim Biophys Acta; 2015 Mar; 1849(3):300-8. PubMed ID: 25482012
[TBL] [Abstract][Full Text] [Related]
13. Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy.
Heikkinen S; Väisänen S; Pehkonen P; Seuter S; Benes V; Carlberg C
Nucleic Acids Res; 2011 Nov; 39(21):9181-93. PubMed ID: 21846776
[TBL] [Abstract][Full Text] [Related]
14. Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening.
Seuter S; Neme A; Carlberg C
PLoS One; 2014; 9(4):e96184. PubMed ID: 24763502
[TBL] [Abstract][Full Text] [Related]
15. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
[TBL] [Abstract][Full Text] [Related]
16. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
[TBL] [Abstract][Full Text] [Related]
17. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
18. The impact of the vitamin D-modulated epigenome on VDR target gene regulation.
Nurminen V; Neme A; Seuter S; Carlberg C
Biochim Biophys Acta Gene Regul Mech; 2018 Aug; 1861(8):697-705. PubMed ID: 30018005
[TBL] [Abstract][Full Text] [Related]
19. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3.
Malinen M; Saramäki A; Ropponen A; Degenhardt T; Väisänen S; Carlberg C
Nucleic Acids Res; 2008 Jan; 36(1):121-32. PubMed ID: 17999998
[TBL] [Abstract][Full Text] [Related]
20. The gene for the transcription factor BHLHE40/DEC1/stra13 is a dynamically regulated primary target of the vitamin D receptor.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
J Steroid Biochem Mol Biol; 2013 Jul; 136():62-7. PubMed ID: 23220548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
